Clinical Trials
3 trialsNCT06976476 2026-03-11
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT04728425 2025-04-27
MG_SCIG
University Health Network, Toronto
Phase 2 Completed
NCT02100969 2021-06-02
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
University of Kansas Medical Center
Phase 2 Completed